Cargando…
Managing antithrombotic treatment in a patient with atrial fibrillation and coronary stent with transient neurological symptoms in cerebral amyloid angiopathy
We present the antithrombotic dilemma in a case with atrial fibrillation and a coronary stent and suspected transient ischemic attacks after diagnosed as a probable cerebral amyloid angiopathy and discuss plausible treatment options for the patient based on the available evidence.
Autores principales: | Ravn, Julie, Sejbæk, Tobias, Bor, Mustafa Vakur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748239/ https://www.ncbi.nlm.nih.gov/pubmed/36523373 http://dx.doi.org/10.1002/ccr3.6624 |
Ejemplares similares
-
Cerebral Amyloid Angiopathy–Related Transient Focal Neurologic Episodes
por: Smith, Eric E., et al.
Publicado: (2021) -
Association of antithrombotic therapy with postoperative rebleeding in patients with cerebral amyloid angiopathy
por: Yanagawa, Taro, et al.
Publicado: (2023) -
Stroke prevention in an octogenarian with atrial fibrillation, cerebral amyloid angiopathy and intracerebral hemorrhage
por: Stöllberger, Claudia, et al.
Publicado: (2023) -
Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020) -
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)